Sol-gel one-pot synthesis in soft conditions of mesoporous silica materials ready for drug delivery system

Journal of Sol-Gel Science and Technology

Volumn 61, Issue 3, 2012, Pages 455-462

  Tourne Peteilh, Corine ^a   Begu, Sylvie ^a   Lerner, Dan A ^a   Galarneau, Anne ^a   Lafont, Ugo ^b   Devoisselle, Jean Marie ^a  

^a CNRS   (France)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Drug delivery; Ibuprofen; Sol gel; Templating; Tween 80

Indexed keywords

DRUG DELIVERY; MESOPOROUS MATERIALS; MICELLES; SILICA; SOL-GEL PROCESS; SOLUBILITY; TARGETED DRUG DELIVERY;

DRUG DELIVERY SYSTEM; IBUPROFEN; MESOPOROUS SILICA MATERIALS; PHARMACEUTICAL EXCIPIENT; POORLY SOLUBLE DRUGS; POORLY WATER-SOLUBLE DRUGS; TEMPLATING; TWEEN 80;

CONTROLLED DRUG DELIVERY;

EID: 84871889669     PISSN: 09280707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10971-011-2646-x     Document Type: Article

References (28)

1. Hörter D, Dressman JB (2010) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Del Rev 46:75-87
2. Liu R (2008) Water-insoluble drug formulation. Taylor & Francis, Boca Raton
3. Aiello R, Cavallaro G, Giammona G, Pasqua L, Pierro P, Testa F (2002) Mesoporous silicate as matrix for drug delivery systems of non-steroidal anti-inflammatory drugs. Stud Surf Sci Catal 142:1165-1172
4. Anderson J, Rosenholm J, Areva S, Linden M (2004) Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro-and mesoporous silica matrices. Chem Mater 16:4160-4167
5. Charnay C, Begu S, Tourne-Peteilh C, Nicole L, Lerner DA, Devoisselle J-M (2004) Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm 57:533-540
6. Tourne-Peteilh C, Brunel D, Begu S, Chiche B, Fajula F, Lerner DA, Devoisselle J-M (2003) Synthesis and characterisation of ibuprofen-anchored MCM-41 silica and silica gel. New J Chem 3:281-286
7. Tourne-Peteilh C, Lerner DA, Charnay C, Nicole L, Bégu S, Devoisselle J-M (2003) The potential of ordered mesoporous for the storage of drugs : the example of a pentapeptide encapsulated in a MSU-Tween 80. Chem Phys Chem 3:281-286
8. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J (2001) A new property of MCM-41: drug delivery system. Chem Mater 13:308-311
9. Vallet-Regi M, Balas F, Colilla M, Manzano M (2007) Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sci 9:768-776
10. Azaïs T, Tourné-Péteilh C, Aussenac F, Baccile N, Coelho C, Devoisselle J-M, Babonneau F (2006) Solid-state NMR study of ibuprofen confined in MCM-41 material. Chem Mater 18: 6382-6390
11. Heikkilä T, Salonen J, Tuura J, Hamdy MS, Mul G, Kumar N, Salmi T, Murzin DY, Laitinen L, Kaukonen AM, Hirvonen J, Lehto V-P (2007) Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm 331:133-138
12. Impurities: guideline for residual solvents (2009) In London-UK, European Medicines Agency, 22
13. Unger K, Rupprecht H, Valentin B, Kircher W (1983) The use of porous and surface modified silicas as drug delivery and stabilizing agents. Drug Dev Ind Pharm 9:69-91
14. Kortesuo P, Ahola M, Karlsson S, Kangasniemi I, Yli-Urpo A, Kiesvaara J (2000) Silica xerogel as an implantable carrier for controlled drug delivery-evaluation of drug distribution and tissue effects after implantation. Biomaterials 21:193-198
15. Kortesuo P, Ahola M, Kangas M, Kangasniemi I, Yli-Urpo A, Kiesvaara J (2000) In vitro evaluation of sol-gel processed spray dried sillica gel microsphères as carrier in controlled drug delivery. Int J Pharm 200:223-229
16. Ahola M, Säilynoja E, Raitavuo M, Vaahtio M, Salonen J, Yli-Urpo A (2001) In vitro release of heparin from silica xerogels. Biomaterials 22:2163-2170
17. Fatnassi M, Tourne-Peteilh C, Cacciaguerra T, Dieudonné P, Devoisselle J-M, Alonso B (2010) Tuning nanophase separation and drug delivery kinetics through spray drying and self-assembly. New J Chem 34:607-610
18. Rowe RC, Sheskey PJ, Owen SC (2006) Handbook of pharmaceutical excipients, 5th edn., Pharmaceutical Press, London
19. Boissière C, Larbot A, Van der Lee A, Kooyman PJ, Prouzet E (2000) A new synthesis of mesoporous MSU-X silica controlled by a two-step pathway. Chem Mater 12:2902-2913
20. Broekhoff JCP, de Boer JH (1968) Studies on pore systems in catalysts-chap. XIII. J Catal 10:377-390
21. Galarneau A, Desplantier D, Dutartre R, Di Renzo F (1999) Micelle-templated silicates as a test bed for methods of mesopore size evaluation. Microporous Mesoporous Mater 27:297-308
22. US Pharmacopeia and national formulary (1999
23. Costa P, Sousa Lobo JM (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Biopharm 13:123-133
24. Gerakis AM, Koupparis MA, Efstathiou CE (1993) Micellar acidbase potentiometric titrations of weak acidic and/or insoluble drugs. J Pharm Biomed Anal 11:33-41
25. Schachter DM, Xiong J, Tirol GC (2004) Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly (ethylene oxide). Int J Pharm 281:89-101
26. Attwood D, Florence AT (1985) Surfactant systems-their chemistry, pharmacy and biology, 2nd edn. Chapman and Hall, London
27. Bass JD, Grosso D, Boissiere C, Belamie E, Coradin T, Sanchez C (2007) Stability of mesoporous oxide and mixed metal oxide materials under biologically relevant conditions. Chem Mater 19:4349-4356
28. Begu S, Aubert Pouëssel A, Lerner DA, Tourne-Peteilh C, Devoisselle J-M (2007) Liposil, a promising composite material for drug storage and release. J Control Release 118:1-6